Disclosures for "Novel Bispecific Degrader BHV-1310 Eliminates Intravascular and Interstitial IgG within Multiple Organs and Anatomical Structures Including the Neuromuscular Junction "
-
Seong Lee has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Seong Lee has stock in Biohaven Pharmaceuticals.
-
Kathleen McGrath has received personal compensation for serving as an employee of Biohaven . Kathleen McGrath has stock in Biohaven.
-
Mrs. Estrella has nothing to disclose.
-
Dr. Yousuf has nothing to disclose.
-
Wes Kazmierski has received personal compensation for serving as an employee of Biohaven Phamaceuticals. Wes Kazmierski has stock in Biohaven Pharmaceuticals. Wes Kazmierski has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. del Carmen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. del Carmen has stock in Biohaven Pharmaceuticals.
-
David Spiegel has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Biohaven. David Spiegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Magnet Biotherapeutics. David Spiegel has stock in Biohaven. David Spiegel has stock in Magnet Biotherapeutics. The institution of David Spiegel has received research support from Biohaven. David Spiegel has received intellectual property interests from a discovery or technology relating to health care.
-
Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Foerster.
-
David Pirman has received personal compensation for serving as an employee of Biohaven. David Pirman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scaffold Tx. David Pirman has stock in Agios.
-
Dr. Bunin has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Bunin has stock in Biohaven Pharmaceuticals. Dr. Bunin has received intellectual property interests from a discovery or technology relating to health care.
-
Author has nothing to disclose
-
Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has stock in BHVN. Dr. Car has received intellectual property interests from a discovery or technology relating to health care.